Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genetic factors influencing the risk of multiple myeloma bone disease

Autor: Johnson, D C, Weinhold, N, Mitchell, J, Chen, B, Stephens, O W, Försti, A, Nickel, J, Kaiser, M, Gregory, W A, Cairns, D, Jackson, G H, Hoffmann, P, Noethen, M M, Hillengass, J, Bertsch, U, Barlogie, B, Davis, F E, Hemminki, K, Goldschmidt, H, Houlston, R S, Morgan, G J

Publikováno v: Leukemia

A major complication of multiple myeloma (MM) is the development of osteolytic lesions, fractures and bone pain. To identify genetic variants influencing the development of MM bone disease (MBD), we analyzed MM patients of European ancestry (totaling

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::227175f30b28d88c9c817bf22d21c3f7
http://europepmc.org/articles/PMC4832071

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A new multiple myeloma classification system that correlates to disease stage and prognosis:Indication of reversible phenotypic plasticity as a hallmark

Autor: Johnsen, Hans Erik, Bødker, Julie Støve, Schmitz, Alexander, Larsen, Steffen Falgreen, Perez-Andres, M., Samur, M. K., Davies, F., Pawlyn, C., Kaiser, M., Johnson, D., Bertsch, U., Broijl, A., van Duin, M., Shah, R., Kjeldsen, Malene Krag, Bergkvist, Kim Steve, Bilgrau, Anders Ellern, Johansen, Preben, El-Galaly, Tarec, Samworth, R., Sonneveld, P., Goldschmidt, H., Morgan, G. J., Orfao, A., Munshi, N, Dybkær, Karen, Bøgsted, Martin

Publikováno v: Johnsen, H E, Bødker, J S, Schmitz, A, Larsen, S F, Perez-Andres, M, Samur, M K, Davies, F, Pawlyn, C, Kaiser, M, Johnson, D, Bertsch, U, Broijl, A, van Duin, M, Shah, R, Kjeldsen, M K, Bergkvist, K S, Bilgrau, A E, Johansen, P, El-Galaly, T, Samworth, R, Sonneveld, P, Goldschmidt, H, Morgan, G J, Orfao, A, Munshi, N, Dybkær, K & Bøgsted, M 2016, ' A new multiple myeloma classification system that correlates to disease stage and prognosis : Indication of reversible phenotypic plasticity as a hallmark ', Haematologica, vol. 101, no. Suppl. 1, S448, pp. 160 . < http://www.haematologica.org/content/101/s1/1.full.pdf+html >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::15d078c3835d6e27d09dc7cc97eb9a8b
https://vbn.aau.dk/da/publications/cdc35de9-6f19-475b-8e69-34d2fda63ebe

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

Autor: Jones, J R, Cairns, D A, Gregory, W M, Collett, C, Pawlyn, C, Sigsworth, R, Striha, A, Henderson, R, Kaiser, M F, Jenner, M, Cook, G, Russell, N H, Williams, C, Pratt, G, Kishore, B, Lindsay, J, Drayson, M T, Davies, F E, Boyd, K D, Owen, R G, Jackson, G H, Morgan, G J

Publikováno v: Blood Cancer Journal

We have carried out the largest randomised trial to date of newly diagnosed myeloma patients, in which lenalidomide has been used as an induction and maintenance treatment option and here report its impact on second primary malignancy (SPM) incidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7a75305c1f1d84ae49e97e7baf308021